Rubidium-82 chloride
A radiopharmaceutical used in cardiac imaging
Rubidium-82 chloride is a radiopharmaceutical used in positron emission tomography (PET) imaging, particularly for assessing myocardial perfusion. It is a radioisotope of rubidium and is commonly used in the form of a generator system known as CardioGen-82.
Chemical properties[edit | edit source]
Rubidium-82 is a radioactive isotope of rubidium with a half-life of approximately 76 seconds. It decays by positron emission, which makes it suitable for PET imaging. The chloride form is used because it is soluble and can be easily administered intravenously.
Medical use[edit | edit source]
Rubidium-82 chloride is primarily used in cardiac imaging to evaluate coronary artery disease. It is injected into the bloodstream, where it mimics the behavior of potassium ions, allowing it to be taken up by myocardial tissue. This uptake is then imaged using PET to assess blood flow to the heart muscle.
CardioGen-82 generator[edit | edit source]
The CardioGen-82 generator is a device used to produce rubidium-82 chloride for clinical use. It contains a parent isotope, strontium-82, which decays to produce rubidium-82. The generator allows for the continuous production of rubidium-82, which is then eluted with a saline solution to produce the rubidium-82 chloride used in PET imaging.
Advantages and limitations[edit | edit source]
Rubidium-82 chloride offers several advantages in cardiac imaging, including rapid imaging times due to its short half-life and high-quality images due to the high energy of the emitted positrons. However, its short half-life also limits its use to facilities with an on-site generator, and the high cost of the generator system can be a barrier.
Safety and precautions[edit | edit source]
As with all radiopharmaceuticals, the use of rubidium-82 chloride requires careful handling to minimize radiation exposure to patients and healthcare workers. The short half-life of rubidium-82 helps reduce the overall radiation dose to the patient.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
